Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4

Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4

Type 2 diabetes (T2D)-associated end-stage kidney disease (ESKD) is a global burden, while the renoprotective effects of metformin remain controversial. In a population-based cohort (2002–2018) including 96,643 patients with T2D observed for 0.7 million person-years, we estimated the risk associatio...

Full description

Bibliographic Details
Main Authors: Aimin Yang, Eric S. H. Lau, Hongjiang Wu, Ronald C. W. Ma, Alice P. S. Kong, Wing Yee So, Andrea O. Y. Luk, Amy W. C. Fu, Juliana C. N. Chan, Elaine Chow
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Pharmaceuticals
Subjects:
metformin
diabetes
cardiovascular disease
end-stage kidney disease
lactic acidosis
mortality
Online Access:https://www.mdpi.com/1424-8247/15/9/1140

Internet

https://www.mdpi.com/1424-8247/15/9/1140

Similar Items